Literature DB >> 10364606

Prenatal diagnosis of parvovirus B19-induced hydrops fetalis by chemiluminescence in situ hybridization.

M Musiani1, P Pasini, M Zerbini, G Gentilomi, A Roda, G Gallinella, E Manaresi, S Venturoli.   

Abstract

Parvovirus B19 can be transmitted transplacentally from the infected mother to the fetus during pregnancy, and hydrops fetalis, abortion, or stillbirth can result. In our study we explored the use of chemiluminescence in situ hybridization to detect B19 DNA on cord blood cells, amniotic fluid cells, and pleuric fluid cells from several cases of hydrops fetalis. B19 DNA was detected by using digoxigenin-labeled probes immunoenzymatically visualized with the chemiluminescent adamantil-1,2-dioxetane phenyl phosphate substrate for alkaline phosphatase. The luminescent signal emitted from the hybridized probes was detected, analyzed, and measured with a high-performance, low-light-level imaging luminograph connected to an optical microscope and to a personal computer for the quantification and localization of the chemiluminescent emission inside individual cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364606      PMCID: PMC85149     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Detection of B19 parvovirus in human fetal tissues by in situ hybridisation.

Authors:  J P Nascimento; N F Hallam; J Mori; A M Field; J P Clewley; K E Brown; B J Cohen
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

2.  Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique.

Authors:  T J Török; Q Y Wang; G W Gary; C F Yang; T M Finch; L J Anderson
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

3.  Intrauterine parvovirus infection associated with hydrops fetalis.

Authors:  T Brown; A Anand; L D Ritchie; J P Clewley; T M Reid
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

4.  In situ detection of B19 DNA in bone marrow of immunodeficient patients using a digoxigenin-labelled probe.

Authors:  G Gentilomi; M Zerbini; M Musiani; G Gallinella; D Gibellini; S Venturoli; M C Re; S Pileri; C Finelli; M La Placa
Journal:  Mol Cell Probes       Date:  1993-02       Impact factor: 2.365

5.  Human parvovirus infection in pregnancy and hydrops fetalis.

Authors:  A Anand; E S Gray; T Brown; J P Clewley; B J Cohen
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

6.  Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.

Authors: 
Journal:  BMJ       Date:  1990-05-05

7.  Efficient parvovirus B19 DNA purification and molecular cloning.

Authors:  G Gallinella; M Musiani; M Zerbini; G Gentilomi; D Gibellini; S Venturoli; M La Placa
Journal:  J Virol Methods       Date:  1993-02       Impact factor: 2.014

8.  Chemiluminescent assay for the detection of viral and plasmid DNA using digoxigenin-labeled probes.

Authors:  M Musiani; M Zerbini; D Gibellini; G Gentilomi; M La Placa; E Ferri; S Girotti
Journal:  Anal Biochem       Date:  1991-05-01       Impact factor: 3.365

9.  Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay.

Authors:  P Cassinotti; M Weitz; G Siegl
Journal:  J Med Virol       Date:  1993-07       Impact factor: 2.327

10.  Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence.

Authors:  F Foto; K G Saag; L L Scharosch; E J Howard; S J Naides
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

View more
  1 in total

1.  Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.

Authors:  Milda Naciute; Diana Mieliauskaite; Rita Rugiene; Rita Nikitenkiene; Ligita Jancoriene; Mykolas Mauricas; Zaiga Nora-Krukle; Modra Murovska; Irute Girkontaite
Journal:  J Gen Virol       Date:  2016-10-07       Impact factor: 3.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.